Severe sepsis and septic shock are an important cause of mortality and morbidity. These illnesses can be triggered by the bacterial endotoxin LPS (lipopolysaccharide) and pro-inflammatory cytokines, particularly TNF-α (tumour necrosis factor-α) and IL (interleukin)-1β. Severity and mortality of sepsis have also been associated with high concentrations of N-PCT (aminoprocalcitonin), a 57-amino-acid neuroendocrine peptide derived from ProCT (procalcitonin). Previous studies in a lethal model of porcine polymicrobial sepsis have revealed that immunoneutralization with IgG that is reactive to porcine N-PCT significantly improves short-term survival. To explore further the pathophysiological role of N-PCT in sepsis, we developed an antibody raised against a highly conserved amino acid sequence of human N-PCT [N-PCT-(44–57)]. This sequence differs by only one amino acid from rat N-PCT. First, we demonstrated the specificity of this antibody in a well-proven model of anorexia induced in rats by central administration of human N-PCT-(1–57). Next we explored further the therapeutic potential of anti-N-PCT-(44–57) in a rat model of lethal endotoxaemia and determined how this immunoneutralization affected LPS-induced lethality and cytokine production. We show that this specific antibody inhibited the LPS-induced early release of TNF-α and IL-1β and increased survival, even if treatment began after the cytokine response had occurred. In addition, anti-N-PCT-(44–57) may increase long-term survival in LPS-treated rats by up-regulating the late production of counter-regulatory anti-inflammatory mediators such as ACTH (adrenocorticotropic hormone) and IL-10. In conclusion, these results support N-PCT as a pro-inflammatory factor in both the early and the late stages of lethal endotoxaemia, and suggest anti-N-PCT as a candidate for septic shock therapy.
Skip Nav Destination
Article navigation
Research Article|
September 01 2010
Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies
Eva Tavares;
Eva Tavares
*Clinical and Experimental Pharmacology Research Unit, Valme University Hospital, Seville 41014, Spain
Search for other works by this author on:
Francisco J. Miñano
*Clinical and Experimental Pharmacology Research Unit, Valme University Hospital, Seville 41014, Spain
†Department of Pharmacology, Pediatrics and Radiology, Faculty of Medicine, University of Seville, Seville 41011, Spain
Correspondence: Professor Francisco J. Miñano (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 04 2010
Revision Received:
June 01 2010
Accepted:
June 23 2010
Accepted Manuscript online:
June 23 2010
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2010 Biochemical Society
2010
Clin Sci (Lond) (2010) 119 (12): 519–534.
Article history
Received:
January 04 2010
Revision Received:
June 01 2010
Accepted:
June 23 2010
Accepted Manuscript online:
June 23 2010
Citation
Eva Tavares, Francisco J. Miñano; Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies. Clin Sci (Lond) 1 December 2010; 119 (12): 519–534. doi: https://doi.org/10.1042/CS20100007
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |